Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial
Go back to Edwards SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial| Edwards Lifesciences (NYSE: EW) | Delayed: 83.41 +0.78 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.63 | 52 Week High | $166.87 | |||
| Open | $83.30 | 52 Week Low | $72.20 | |||
| Day High | $84.12 | P/E | 24.25 | |||
| Day Low | $81.16 | EPS | $3.44 | |||
| Volume | 4,011,680 | |||||
